hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 7.90
-0.15 (-1.86%)
Mar 4, 2026, 4:06 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 55.11 million as of March 4, 2026. Its market cap has decreased by -54.49% in one year.
Market Cap
55.11M
Enterprise Value
46.53M
Revenue
54.47M
Ranking
n/a
PE Ratio
10.53
Stock Price
7.90
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 55.11M, an increase of 219.71%. That is a compound annual growth rate of 19.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 55.11M | 28.57% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 128.68M |
| 4basebio | 83.58M |
| Bioventix | 75.76M |
| Hemogenyx Pharmaceuticals | 62.33M |
| Faron Pharmaceuticals Oy | 59.05M |
| Ondine Biomedical | 53.25M |
| ImmuPharma | 36.70M |
| Poolbeg Pharma | 28.91M |